The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients

Terminated

• Conditions: Asthma

• Registration Number: NCT00575445
• Lead Sponsor: Akron Children's Hospital

Brief Summary

The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-11
• Study First Submitted: 2007-12-14
• Study First Submitted QC: 2007-12-14
• Study First Posted: 2007-12-18
• Primary Completion: 2009-12
• Status Verified: 2015-03
• Study Completion: 2015-03
• Last Update Submitted: 2015-03-24
• Last Update Posted: 2015-03-25

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Clinical diagnosis of asthma by pediatric pulmonologist
• Age 6-18 years

Exclusion Criteria

• Age <6 years or >18 years
• history of bronchopulmonary dysplasia
• history of cystic fibrosis
• history of primary ciliary dyskinesia
• current acute asthma exacerbation
• current acute viral upper respiratory infection
• recent ingestion of nitrate-rich foods

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Exhaled nitric oxide level	One office visit

Trial Locations

Locations (1)

Akron Children's Hospital; 🇺🇸 Akron, Ohio, United States